The North America Intra-abdominal Pressure Measurement Devices Market would witness market growth of 10.4% CAGR during the forecast period (2020-2026). IAH & ACS can cause death and morbidity caused by cardiac output, altered respiratory mechanics, and reduced venous return. This leads to impaired hepatic blood flow, respiratory failure, poor splanchnic perfusion, elevated intracranial pressure, renal failure, and end-organ dysfunction, and other possible complications. Therefore, early detection and diagnosis of IAH & ACS using IPMDs are important for improving morbidity and mortality among patients.
The prevalence of IAH increases in more critically ill patients and is associated with significantly increased morbidity and mortality. In the presence of tense abdominal distension, IAH and ACS develop. The increase in IAP causes tissue hypoperfusion that can lead to multiple organ dysfunction syndromes and impair the functioning of almost every organ system. ACS is potentially fatal, with a mortality rate of between 40 and 100 percent. Intra-Abdominal Pressure Monitoring is an essential tool for the diagnosis, prevention, and management of IAH and ACS. IAP monitoring is of significant importance in improving patient survival among patients in the IAH and/or ACS Intensive Care Unit.
Countries such as the U.S. and Canada have seen increasing cases of ICU admissions and urological disorders like interstitial cystitis, bladder cancer, prostate cancer, and bowel syndrome in recent times. According to the Society of Critical Care Medicine (SCCM) 2019, approximately 5.0 million patients in the U.S. are admitted to ICUs for invasive or intensive monitoring every year. In addition, according to the Canadian Cancer Society Statistics 2020, it is predicted that 23,300 men will be diagnosed with prostate cancer in 2020. Increased prevalence of IAH and ACS among ICU patients and related disorders is therefore expected to fuel demand growth for intra-abdominal pressure measurement devices during the forecast period.
In addition, a growing number of IAH and ACS cases in developed and emerging countries have led to the launch of technically advanced products on the market for intra-abdominal pressure measurement instruments. For example, Potrero Medical's Accuryn Monitoring System, which is a next-generation diagnostic device, helps monitor patients' vital signs in real-time and incorporates them into the Electronic Medical Record (EMR) system.
Based on Product, the market is segmented into Equipment and Disposables. Based on Procedure, the market is segmented into Abdomen and Muscle. Based on Application, the market is segmented into Intra-abdominal Hypertension and Intra-compartment Pressure. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Intra-abdominal Pressure Measurement Devices Market in North America is expected to register a CAGR of 10.4% during the forecast period (2020-2026)
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Stryker Corporation, ConvaTec Group PLC, Spiegelberg GmbH & Co. KG, Gaeltec Devices Ltd., Potrero Medical, Inc., Medline Industries, Inc. (Centurion Medical Products Corporation), Critical Care Diagnostics, Inc., SSEM Mthembu Medical (Pty.) Ltd., and Biometrix BV (Q Holding Company).
Market Segmentation:
By Product
By Procedure
By Application
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
